BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Mesothelin; programmed cell death 1 (PD-1; PDCD1; CD279)

August 4, 2016 7:00 AM UTC

Mouse studies suggest chimeric antigen receptor (CAR) T cells engineered to express a dominant-negative variant of PD-1 could help treat mesothelioma. The CAR T cells were engineered to express a meso...